Evaluation and Follow-up of Clinically Euthyroid Children with Normal Free T4 and Suppressed TSH

被引:2
作者
Vaidyanathan, Priya [1 ]
Koplowitz, Paul B. [1 ]
机构
[1] Childrens Natl Med Ctr, Dept Endocrinol, Washington, DC 20010 USA
关键词
SUBCLINICAL HYPERTHYROIDISM; DISEASE; OVERT;
D O I
10.1515/jpem.2010.160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim Although subnormal TSH between 0 10 4 mIU/L is fairly common and benign, suppression of TSH to < 0 1mIU/L with normal free T4 is less common and more worrisome We have conducted a retrospective chart review of a collection of such cases and have summarized the features and outcome on follow up Methods We studied 23 consecutive patients referred from 2005-07 to our pediatric endocrine clinic with TSH < 0 1 mIU/L and free T4 in the range of 0 8-2 ng/dl We collected historical, clinical and laboratory data, and analyzed their outcome Results The natural evolutions of these subjects were separated into 4 groups Group 1, 14 subjects, (61%) became euthyroid within a mean of 3 7 months Group 2, 4 subjects, (17%) became hypothyroid within a mean of 2 8 months Group 3, 2 subjects (9%) progressed to overt hyperthyroidism Group 4, 3 subjects (13%) had persistently suppressed TSH, 8-14 months after initial testing, of which one had a multinodular goiter and had a thyroidectomy Elevated thyroid peroxidase antibody (TPO) was seen in 54 5% of those tested Conclusion Only 2/23 in our series became overtly hyperthyroid Substantial number of subjects had a short period of transient TSH suppression that resolved spontaneously Markers suggestive of autoimmune thyroid disease were consistently seen in group 2 and less so in others It is prudent to observe such cases in the short term with serial follow up TSH, free T4 and T3, and to reserve further testing and treatment for those who become symptomatic or do not resolve
引用
收藏
页码:993 / 997
页数:5
相关论文
共 15 条
  • [1] *AM ASS CLIN END, 2006, MED GUID CLIN PRACT
  • [2] The impact of overt and subclinical hyperthyroidism on skeletal muscle
    Brennan, Michael D.
    Powell, Claudia
    Kaufman, Kenton R.
    Sun, Pi Chang
    Bahn, Rebecca S.
    Nair, K. Sreekumaran
    [J]. THYROID, 2006, 16 (04) : 375 - 380
  • [3] Thyroid status, cardiovascular risk, and mortality in older adults
    Cappola, AR
    Fried, LP
    Arnold, AM
    Danese, MD
    Kuller, LH
    Burke, GL
    Tracy, RP
    Ladenson, PW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (09): : 1033 - 1041
  • [4] Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction
    Gulseren, S
    Gulseren, L
    Hekimsoy, Z
    Cetinay, P
    Ozen, C
    Tokatlioglu, B
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (01) : 133 - 139
  • [5] Subclinical hyperthyroidism
    Haden, ST
    Marqusee, E
    Utiger, RD
    [J]. ENDOCRINOLOGIST, 1996, 6 (04) : 322 - 327
  • [6] JOHN PW, 2005, ARCH INTERN MED, V165, P2467
  • [7] Hashitoxicosis in children: Clinical features and natural history
    Nabhan, ZM
    Kreher, NC
    Eugster, FA
    [J]. JOURNAL OF PEDIATRICS, 2005, 146 (04) : 533 - 536
  • [8] PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77
  • [9] Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R)
    Pohlenz, Joachim
    Pfarr, Nicole
    Krueger, Silvia
    Hesse, Volker
    [J]. ACTA PAEDIATRICA, 2006, 95 (12) : 1685 - 1687
  • [10] Reiterer E, 2003, ACTA MED AUST, V30, P107